Velocity, an integrated site organization for clinical trials, completed the acquisition of the medical facilities providers Vitalink Research and National Research Institute. Financial terms were not disclosed. "Velocity has moved into the next phase of its development. We have accelerated the pace of site acquisitions this year, bringing VitaLink and NRI's experience into our fully integrated site network," Dr G. Paul Evans, Velocity CEO and President.